Abstract:
PURPOSE: A composition containing scallop components is provided to prevent and treat thrombus-associated diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating thrombus-associated diseases contains scallop components as an active ingredient. The scallop extract is isolated using water, acetone, dimethyl ether, low alcohol of 1-4 carbon atoms, or mixture solvent thereof. The scallop is Patinopecten yessoensis, Pecten albicans, Chlamys farreri, Chlamys swifti, Patinopecten(Mizuhopecten) tokyoensis, or Lima sowerbyi. A health food for preventing and treating thrombus-associated diseases contains scallop components as an active ingredient. The health food is manufactured in the form of powder, granule, tablet, capsule, syrup, or beverage.
Abstract:
PURPOSE: An antibacterial composition containing Undaria pinnatifida (Garney) Suringar extract is provided to ensure antibacterial activity against pathogenic bacteria and to be used in a pharmaceutical composition and health food. CONSTITUTION: An antibacterial contains Undaria pinnatifida (Garney) Suringar extract as an active ingredient. The composition has antibacterial activity against Escherichia coli, Bacillus subtilis, Candida albicans, Streptococcus mutans, or Staphylococcus aureus. The Undaria pinnatifida (Garney) Suringar extract is isolated using water, low alcohol of C1-C4, hexane, chloroform, methylene chloride, ethyl acetate, glycerin, butylene glycol, or mixture solvent.
Abstract:
본 발명은 명란젓, 명란젓 극성용매 추출물 또는 극성용매 불용성 추출잔사를 유효성분으로 함유하는 비만 또는 고지혈증 및 동맥경화성 혈관계 질환의 예방 및 치료를 위한 조성물에 관한 것으로, 상세하게는 본 발명의 명란젓, 명란젓 극성용매 추출물 또는 극성용매 불용성 추출잔사는 고지혈증을 유발시킨 동물모델에서 간조직 및 분변 중 지질 함량을 감소시키고, 혈청 중의 중성지방, 콜레스테롤, 인지질, 과산화지질 및 Hydroxyl radical 함량을 감소시키며, 혈청 중 SOD 활성을 증진시킴을 확인하였으며, 항비만, 항암, 항산화 효과가 탁월한 것으로 알려져 있는 공역지방산이 다량 함유되어 있음을 확인한 바, 비만 또는 고지혈증 및 동맥경화성 혈관계 질환의 예방 및 치료에 유용한 약학조성물 및 건강기능식품에 이용될 수 있다. 명란젓, 비만, 고지혈증, 콜레스테롤, 항산화
Abstract:
본 발명은 명태식해를 유효성분으로 함유하는 조성물에 관한 것으로, 상세하게는 본 발명의 명태식해는 Acetaminophen에 의해 간손상이 유발된 실험동물에서 AST, ALT, Aminopyrine demethylase 및 Aniline hydroxylase의 활성을 억제시키고, 지질과산화, cytochrome P-450 및 cytochrome b5의 함량을 감소시키며, 글루타티온 함량을 증가시키고, Glutathione S-transferase, γ-Glutamylcystein synthetase 및 Glutathione reductase의 활성 증진시키는 효과를 확인함으로써, 이를 포함하는 조성물은 산화적 스트레스로 인한 간 질환의 예방 및 치료를 위한 약학 조성물 또는 건강기능식품으로 유용하게 이용될 수 있다. 명태식해, AST, ALT, 항산화 효소, 간 질환
Abstract:
PURPOSE: A composition containing Patinopecten yessoensis ingredient is provided to suppress plasma coagulation and ensure antibacterial effect. CONSTITUTION: A pharmaceutical composition for preventing or treating bacterial infectious diseases or thrombosis-associated diseases contains Patinopecten yessoensis ingredient as an active ingredient. The Patinopecten yessoensis extract is obtained using water including purified water, acetone, dimethyl ether, low alcohol of 1-4 carbon atoms or mixture solvent thereof. The used Patinopecten yessoensis is Patinopecten yessoensis, Pecten albicans, Chlamys farreri, Chlamys swifti, Patinopecten (Mizuhopecten) tokyoensis, or Lima sowerbyi. The composisiton contains 0.01-50 weight% of Patinopecten yessoensis extract. A health food for preventing and treating infectious diseases or thrombosis-associated diseases contains Patinopecten yessoensis extract as an active ingredient. The health food is manufactured in the form of powder, granule, tablet, capsule, syrup, or beverage.
Abstract:
PURPOSE: A composition containing sea urchin extract with detoxification and antioxidation is provided. CONSTITUTION: A pharmaceutical composition for preventing and treating liver diseases contains dried powder of sea urchin, polar solvent soluble extract or polar solvent insoluble residue of the dried powder as an active ingredient. The sea urchin includes Anthocidaris crassispina, Hemicentrotus pulcherrimus, Pseudocentrotus depressus or Strongylocentrotus internmedius. The sea urchin includes eggs, intestine or shell. The polar solvent soluble extract contains an extract obtained using water, low alcohol or mixture solvent thereof.
Abstract translation:目的:提供含有解毒和抗氧化作用的海胆提取物的组合物。 构成:用于预防和治疗肝脏疾病的药物组合物含有海胆干燥粉末,极性溶剂可溶性提取物或干粉末的极性溶剂不溶残留物作为活性成分。 海胆包括Ant includes ina ina,,,,,,,,,。。。。。。。。。。。。。。。。。。。 海胆包括鸡蛋,肠或壳。 极性溶剂可溶性提取物含有使用水,低级醇或其混合溶剂获得的提取物。
Abstract:
PURPOSE: A composition containing dried powder of sand lance fraction or its extract is provided to suppress pain using an animal model by inducing acetic acid pain test, heat plate and tail flick test. CONSTITUTION: A pharmaceutical composition for preventing and treating pain contains dried powder or its extract of sand lance fraction as an active ingredient. The extract of sand lance fraction is obtained by heating the sand lance fraction at 60°C-150°C for 12 to 48 hours. The pain is the headache, toothache, backache, burn ache, neuralgia, period pains or arthralgia. The pharmaceutical composition contains 0.1-50 weight% of the dried powder or its extract based on the total weight.
Abstract:
PURPOSE: A composition containing dried powder and extract of chub mackerel fraction is provided to reduce total cholesterol and blood triglyceride content. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperlipidemia contains 0.1-50 weight% of dried powder or extract of chub mackerel fraction as an active ingredient. The fraction of the chub mackerel is head, cartilage, shell, muscle, eye, gill, total body of the fish. A method for preparing the dried powder of chub mackerel fraction comprises: a step of washing and removing foreign material and salt from the chub mackerel; and a step of cutting head, cartilage, shell, muscle, eye, gill, and total body. The extract is isolated using water, alcohol and spirit extract solvent.
Abstract:
PURPOSE: A method for manufacturing collagen isolated from the skin of bigeye tuna is provided to produce high quality of collagen with high solubility and emulsion stability. CONSTITUTION: A method for manufacturing collagen isolated from the skin of bigeye tuna comprises: a step for washing the skin of the bigeye tuna which is stored at -30 °C to -100 °C; a step for treating the skin with 0.05 ~ 10.0 %(w/v) of alkali solution; a step for washing and neutralizing with distilled water; a step for adding 0.05 ~ 10.0 N of acid to the skin, then stirring and extracting; a step for separating extracted liquid and residue using a centrifuge; and a step for drying to obtain acid soluble collagen (AC); a step for adding 0.5 ~ 5.0 N of acid; a step for adding 0.5 ~ 10% of pepsin and stirring and hydrolyzing for 1 to 60 hours; a step for separating extract liquid and residue using a filter; a step for adding NaCl to adjust the concentration to 1-10 % and neutralizing precipitates; and a step for freeze-drying to obtain a pepsin soluble collagen (PC).